Prevention and Control Core
Prevention and Control Core
批准号:
7925430
负责人:
ELIZABETH A. WALKER
金额:
$44.19万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2015-03-31
关键词:
Basic ScienceBehavior TherapyBehavioralBiological MarkersClinicalClinical InvestigatorClinical ResearchClinical TrialsClinical and Translational Science AwardsCollaborationsCommunitiesCommunity HealthConsultationsCountyData SetDatabasesDevelopmentDiabetes MellitusDisciplineEducational workshopEffectivenessEpidemiologyEvaluationEvaluation MethodologyFacultyFosteringFundingGrowthGuidelinesInstitutesInstitutionInterventionLeadershipMeasurementMentorsMetabolicMetabolismMethodologyMethodsMinorityMissionObesityOutcome MeasurePhysiologyPopulationPositioning AttributePrevalencePreventionProductivityPublic HealthRecording of previous eventsResearchResearch DesignResearch InfrastructureResearch MethodologyResearch PersonnelResearch Project GrantsResearch SupportResourcesServicesStagingStructureStudy SubjectTechnical ExpertiseTrainingTranslational Researchcareer developmentcommunity based participatory researchdiabetes controleffective interventionhealth disparityinnovationmedical schoolsmeetingsmemberpreventprogramspsychosocialsocialsocial capitalsuccess
中文摘要
爱因斯坦DRTC的预防和控制(P&C)核心建立在其富有成效的32年历史的基础上,创建了三个功能单元的新基础设施,并吸引了具有社区和心理社会专业知识和创新方法的教师。各职能单位之间的相互配合和协同作用对P&C核心和DRTC整体的成功至关重要。研究设计的连续性为研究糖尿病相关问题创造了许多替代方法,所有这些方法都集中在改善糖尿病相关问题上。
健康差距。临床研究方法部门(CRMU)的主要使命是通过适用于糖尿病的临床研究方法的咨询、培训和指导,促进高质量的糖尿病转化研究。其目标包括:1)提高糖尿病相关临床试验、临床生理学和转化研究的质量和范围; 2)促进新的糖尿病临床和转化研究人员的职业发展。行为干预与评价
方法学单位(BIEM)促进行为干预措施的开发和实施,并为预防和控制糖尿病及其并发症的研究提供全面的评估支持。其目标包括:1)提高调查人员制定有效干预措施的程度; 2)协助调查人员应用严格的评估方法。虽然P&C核心的第三个单元,社会环境研究方法(SERM)单元是新的,它促进了我们的
社区和健康差距糖尿病研究的优势。tfiis建议的单位的目标包括:1)通过提供评估和干预的专家资源,包括基于社区的参与性研究,增加社区和社会资本的发展;和2)使社区参与糖尿病相关的研究,以减少健康差距。前一个目标将由新的教师和资源提供;后者将通过社区的新合作促进生产力
和公共卫生机构的水平。总之,爱因斯坦P&C核心建立在其研究优势及其与DRTC作为一个整体的协同作用,同时热情支持我们的医学院领导。
英文摘要
The Prevention and Control (P&C) Core of the Einstein DRTC builds on its productive 32-year history by creating a new infrastnjcture of three functional units and by attracting faculty with community and psychosocial expertise and innovative methodologies. The interface and synergy among the functional units are crucial to the success of the P&C Core and the DRTC as a whole. The continuum of research designs creates many altematives for studying diabetes-related problems, all of which are focused on ameliorating
health disparities. The primary mission of the Clinical Research Methodology Unit (CRMU) is to promote high-quality diabetes translational research, through consultation, training and mentoring in clinical research methods applicable to diabetes. Its objectives include: 1) to increase the quality and scope of diabetes related clinical trials, clinical physiology and translational research; and 2) to foster the career development of new diabetes clinical and translational investigators. The Behavioral Interventbn and Evaluation
Methodology Unit (BIEM) facilitates the development and implementation of behavioral interventions and provides comprehensive evaluation support for research to prevent and control diabetes and its complications. Its objective include: 1) to increase the extent to which investigators develop effective interventions; and 2) to assist investigators to apply rigorous evaluation methods. Although the third unit of the P&C Core, the Social-Environmental Research Methodology (SERM) unit is new, it promotes our
strengths in community and health disparities diabetes research. The objectives of tfiis proposed unit include: 1) to increase community and social capital development by providing expert resources for assessment and intervention, including community-based participatory research; and 2) to engage the community in diabetes-related research to reduce health disparities. The fonner objective will be provided by new faculty and resources; the latter will foster productivity through new collaborations at the community
and public health agency levels. In summary, the Einstein P&C Core builds on its research strengths and its synergy with the DRTC as a whole, while enthusiastically supported by our medical school leadership.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translating the Diabetes Prevention Program to Engage Men in Disadvantaged Areas
-
批准号:8755373
-
项目类别:
-
资助金额:$21.2万
-
财政年份:2014
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:8134085
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7408088
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7245289
-
项目类别:
-
资助金额:$49.39万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7668867
-
项目类别:
-
资助金额:$12.73万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7802931
-
项目类别:
-
资助金额:$49.35万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:8069142
-
项目类别:
-
资助金额:$43.76万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7617249
-
项目类别:
-
资助金额:$60.85万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:7186194
-
项目类别:
-
资助金额:$3.31万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:7071213
-
项目类别:
-
资助金额:$67.33万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:6897922
-
项目类别:
-
资助金额:$65.4万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:6757842
-
项目类别:
-
资助金额:$63.35万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:7231944
-
项目类别:
-
资助金额:$47.31万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:7155825
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:6617212
-
项目类别:
-
资助金额:$59.8万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6194634
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6384924
-
项目类别:
-
资助金额:$63.05万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6799991
-
项目类别:
-
资助金额:$74.34万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6665049
-
项目类别:
-
资助金额:$72.32万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6735916
-
项目类别:
-
资助金额:$2.46万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
海外基金